The Valley Desk

NCT00158860 · Interventional trial

A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.

Overall registry status Completed

Phase 4

Conditions Herpes Genitalis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov